Tilray Brands, Inc. Cost of Revenue
Tilray Brands, Inc. (TLRY) reported Cost of Revenue of $655.01 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-28
- Tilray Brands, Inc. cost of goods and services sold for the quarter ending 2026-05-31 was $191.19M, a 21.86% increase year-over-year.
- Tilray Brands, Inc. cost of goods and services sold for the quarter ending 2026-02-28 was $151.78M, a 13.46% increase year-over-year.
- Tilray Brands, Inc. cost of goods and services sold for the quarter ending 2025-11-30 was $160.01M, a 6.87% increase year-over-year.
- Tilray Brands, Inc. cost of goods and services sold for the quarter ending 2025-08-31 was $152.03M, a 8.33% increase year-over-year.
- Tilray Brands, Inc. cost of goods and services sold for fiscal 2026 was $655.01M, a 12.79% increase from fiscal 2025.
- Tilray Brands, Inc. cost of goods and services sold for fiscal 2025 was $580.74M, a 2.68% increase from fiscal 2024.
- Tilray Brands, Inc. cost of goods and services sold for fiscal 2024 was $565.59M, a 17.79% increase from fiscal 2023.
- Tilray Brands, Inc. cost of goods and services sold for fiscal 2023 was $480.16M, a 6.14% decline from fiscal 2022.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|---|
| 2026-05-31 | $191.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $342.97M derived: sum of 2 quarters · filed 2026-07-28 | $502.98M derived: sum of 3 quarters · filed 2026-07-28 | $655.01M 10-K · filed 2026-07-28 | ||
| 2026-02-28 | $151.78M 10-Q · filed 2026-04-01 | $311.79M derived: sum of 2 quarters · filed 2026-04-01 | $463.82M 10-Q · filed 2026-04-01 | $620.72M derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2025-11-30 | $160.01M 10-Q · filed 2026-01-08 | $312.04M 10-Q · filed 2026-01-08 | $468.94M derived: sum of 3 quarters · filed 2026-07-28 | $602.71M derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2025-08-31 | $152.03M 10-Q · filed 2025-10-09 | $308.93M derived: sum of 2 quarters · filed 2026-07-28 | $442.70M derived: sum of 3 quarters · filed 2026-07-28 | $592.43M derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2025-05-31 | $156.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $290.67M derived: sum of 2 quarters · filed 2026-07-28 | $440.40M derived: sum of 3 quarters · filed 2026-07-28 | $580.74M 10-K · filed 2026-07-28 | ||
| 2025-02-28 | $133.77M 10-Q · filed 2026-04-01 | $283.50M derived: sum of 2 quarters · filed 2026-04-01 | $423.84M 10-Q · filed 2026-04-01 | $571.37M derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2024-11-30 | $149.73M 10-Q · filed 2026-01-08 | $290.07M 10-Q · filed 2026-01-08 | $437.60M derived: sum of 3 quarters · filed 2026-07-28 | $576.54M derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2024-08-31 | $140.34M 10-Q · filed 2025-10-09 | $287.87M derived: sum of 2 quarters · filed 2026-07-28 | $426.81M derived: sum of 3 quarters · filed 2026-07-28 | $573.18M derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2024-05-31 | $147.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $286.48M derived: sum of 2 quarters · filed 2026-07-28 | $432.84M derived: sum of 3 quarters · filed 2026-07-28 | $565.59M 10-K · filed 2026-07-28 | ||
| 2024-02-29 | $138.94M 10-Q · filed 2025-04-08 | $285.31M derived: sum of 2 quarters · filed 2025-04-08 | $418.06M 10-Q · filed 2025-04-08 | $535.08M derived: sum of 4 quarters · filed 2025-07-29 | ||
| 2023-11-30 | $146.36M 10-Q · filed 2025-01-10 | $279.12M 10-Q · filed 2025-01-10 | $396.14M derived: sum of 3 quarters · filed 2025-07-29 | $553.43M derived: sum of 4 quarters · filed 2025-07-29 | ||
| 2023-08-31 | $132.75M 10-Q · filed 2024-10-10 | $249.78M derived: sum of 2 quarters · filed 2025-07-29 | $407.07M derived: sum of 3 quarters · filed 2025-07-29 | $508.32M derived: sum of 4 quarters · filed 2025-07-29 | ||
| 2023-05-31 | $117.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $274.31M derived: sum of 2 quarters · filed 2025-07-29 | $375.57M derived: sum of 3 quarters · filed 2025-07-29 | $480.16M 10-K · filed 2025-07-29 | ||
| 2023-02-28 | $157.29M 10-Q · filed 2024-04-09 | $258.54M derived: sum of 2 quarters · filed 2024-04-09 | $363.14M 10-Q · filed 2024-04-09 | $523.20M derived: sum of 4 quarters · filed 2024-10-10 | ||
| 2022-11-30 | $101.25M 10-Q · filed 2024-01-09 | $104.01M 10-Q · filed 2023-01-09 | $205.85M 10-Q · filed 2024-01-09 | $208.61M 10-Q · filed 2023-01-09 | $365.91M derived: sum of 3 quarters · filed 2024-10-10 | $477.95M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $104.60M 10-Q · filed 2024-10-10 | $264.65M derived: sum of 2 quarters · filed 2024-10-10 | $376.70M derived: sum of 3 quarters · filed 2024-10-10 | $499.08M derived: sum of 4 quarters · filed 2024-10-10 | ||
| 2022-05-31 | $160.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $272.10M derived: sum of 2 quarters · filed 2024-07-30 | $394.49M derived: sum of 3 quarters · filed 2024-07-30 | $511.56M 10-K · filed 2024-07-30 | ||
| 2022-02-28 | $112.04M 10-Q · filed 2023-04-10 | $234.43M derived: sum of 2 quarters · filed 2023-04-10 | $351.50M 10-Q · filed 2023-04-10 | $471.24M derived: sum of 4 quarters · filed 2023-07-26 | ||
| 2021-11-30 | $122.39M 10-Q · filed 2023-01-09 | $239.46M 10-Q · filed 2023-01-09 | $359.19M derived: sum of 3 quarters · filed 2023-07-26 | |||
| 2021-08-31 | $117.07M 10-Q · filed 2022-10-07 | $236.81M derived: sum of 2 quarters · filed 2023-07-26 | ||||
| 2021-05-31 | $119.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $389.90M 10-K · filed 2023-07-26 | ||||
| 2021-03-31 | $34.52M 10-Q · filed 2021-05-10 | |||||
| 2021-02-28 | $93.44M 10-Q · filed 2022-04-06 | $187.62M derived: sum of 2 quarters · filed 2022-04-06 | $270.17M 10-Q · filed 2022-04-06 | |||
| 2020-12-31 | $185.83M 10-K · filed 2021-02-19 | |||||
| 2020-11-30 | $94.18M 10-Q · filed 2022-01-10 | $176.72M 10-Q · filed 2022-01-10 | ||||
| 2020-08-31 | $82.55M 10-Q · filed 2021-10-07 | |||||
| 2020-05-31 | $309.27M 10-K · filed 2022-07-28 | |||||
| 2020-03-31 | $41.23M 10-Q · filed 2021-05-10 | |||||
| 2019-12-31 | $190.47M 10-K · filed 2021-02-19 | |||||
| 2019-05-31 | $135.79M 10-K · filed 2021-07-28 | |||||
| 2018-12-31 | $28.86M 10-K · filed 2021-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |